Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients

NCT01257451 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

431

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Vildagliptin
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals